scispace - formally typeset
S

Sarah E. Bohndiek

Researcher at University of Cambridge

Publications -  176
Citations -  5551

Sarah E. Bohndiek is an academic researcher from University of Cambridge. The author has contributed to research in topics: Medicine & Hyperspectral imaging. The author has an hindex of 30, co-authored 141 publications receiving 4254 citations. Previous affiliations of Sarah E. Bohndiek include Engineering and Physical Sciences Research Council & University College London.

Papers
More filters
Journal ArticleDOI

Contrast agents for molecular photoacoustic imaging

TL;DR: The physical, chemical and biochemical characteristics of the existing photoacoustic contrast agents are critically reviewed, highlighting key applications and present challenges for molecular PAI.
Journal ArticleDOI

Imaging biomarker roadmap for cancer studies.

James P B O'Connor, +78 more
TL;DR: Experts assembled to review, debate and summarize the challenges of IB validation and qualification produced 14 key recommendations for accelerating the clinical translation of IBs, which highlight the role of parallel (rather than sequential) tracks of technical validation, biological/clinical validation and assessment of cost-effectiveness.
Journal ArticleDOI

Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors

TL;DR: The formation of hyperpolarized 13C-labeled malate from [1,4-13C2]fumarate appears to be a sensitive marker of tumor cell death in vivo and could be used to detect the early response of tumors to treatment.
Journal ArticleDOI

Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy

TL;DR: This review highlights the most significant molecules investigated to date in preclinical cancer models, either in terms of their demonstrated metabolism in vivo or the biological processes that they can probe, and techniques to image these molecules are discussed.
Journal ArticleDOI

Hyperpolarized [1-13C]-ascorbic and dehydroascorbic acid: vitamin C as a probe for imaging redox status in vivo.

TL;DR: This study demonstrates that hyperpolarized 13C-labeled vitamin C could be used as a noninvasive biomarker of redox status in vivo, which has the potential to translate to the clinic.